F10 and peripheral arterial disease: C5. Antiplatelet agents with vitamin K antagonist, direct thrombin inhibitor, or factor Xa inhibitors in patients with stable coronary, cerebrovascular, or peripheral arterial disease without a clear indication for anticoagulant therapy (no added benefit from dual therapy)